跳到主要内容
  • Sign in
    Welcome !
    My account
    Logout

Innovid Corp. (CTV) Stock Forecast 2025 - AI Price Prediction & Analysis

Innovid Corp. (CTV) AI Stock Price Forecast & Investment Analysis

Innovid Corp. Stock Price Chart and Technical Analysis

Loading Innovid Corp. interactive price chart and technical analysis...

Innovid Corp. (CTV) - Comprehensive Stock Analysis & Investment Research

Deep dive into Innovid Corp.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Innovid Corp., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Innovid Corp.: Innovid Corp. operates in the Technology sector, making it an emerging small-cap investment.

Innovid Corp. (Stock Symbol: CTV) is a leading company in the Technology sector , specifically operating within the Services-Prepackaged Software industry.

The organization employs approximately 531 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Innovid Corp.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Innovid Corp.: With $29M in annual revenue and -72.6% net margin, the company demonstrates developing profitability.

Annual Revenue: $29 million generating a -72.6% net profit margin .

Market Capitalization: $466 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -34.7% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Innovid Corp. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Innovid Corp.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Innovid Corp. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Innovid Corp.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Innovid Corp.: Market positioning analysis based on available financial and operational metrics.

Innovid Corp. strategically competes in the highly dynamic Services-Prepackaged Software marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 55.9% gross margin, indicating strong pricing power and operational efficiency.

Innovid Corp. (CTV) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Innovid Corp. stock analysis.

Loading Innovid Corp. comprehensive fundamental analysis and insider trading data...

Deep dive into Innovid Corp.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Innovid Corp. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Innovid Corp.: With a P/E ratio of -21.59, the market sees the stock as potentially undervalued.

P/E Ratio -21.59x
P/B Ratio 2.34x
Market Cap $466M
EPS $0.03
Book Value/Share $1.35
Revenue/Share $0.39
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Innovid Corp. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Innovid Corp.: An ROE of -34.7% indicates room for improvement in shareholder value creation.

ROE -34.7%
ROA -27.2%
ROIC -32.9%
Gross Margin 55.9%
Operating Margin -3.0%
Net Margin -72.6%
EBT Margin -16.3%
Tax Rate 20.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Innovid Corp.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Innovid Corp.: A current ratio of 3.52 indicates strong liquidity.

Current Ratio 3.52x
Quick Ratio 3.26x
D/E Ratio 0.02x
Financial Leverage 1.27x
Interest Coverage -1.3x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Innovid Corp.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Innovid Corp.: Free cash flow of $-20M indicates cash challenges that need attention.

Operating Cash Flow $-15M
Free Cash Flow $-20M
Capital Spending $-5M
FCF/Sales -19.9%
CapEx/Sales 4.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Innovid Corp. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Innovid Corp.: An asset turnover of 0.38x suggests room for improvement in asset utilization.

Asset Turnover 0.38x
Receivables Turnover 2.5x
Fixed Assets Turnover 9.7x
Days Sales Outstanding 144 days
Payables Period 68 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Innovid Corp.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Innovid Corp.: With annual revenue of $29M, Innovid Corp. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $29M
Operating Income $15M
Net Income $1M
R&D Expense $2M
SG&A Expense $68M
Cost of Goods Sold $6M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 35%
Cash & Short-term Investments 18%
Total Liabilities 22%
Short-term Debt 2%
Accounts Receivable 15%
Dividend & Shareholder Information
Shares Outstanding 148M
Growth Metrics (YoY)
EPS Growth 1.0%

Latest Innovid Corp. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Innovid Corp. (CTV) stock price and investment outlook.

, source: Business Insider

(RTTNews) - Below are the earnings highlights for Innovid Corp. (CTV): Earnings: $4.67 million in Q3 vs. -$2.73 million in the same period last year. EPS: $0.03 in Q3 vs. -$0.02 in the same period ...

, source: Seeking Alpha

Thank you, operator. Before we begin, I'll remind you that today's call may contain forward-looking statements and that the safe harbor statement in today's earnings release available on our Investor ...

, source: Business Wire

NEW YORK--(BUSINESS WIRE)--Innovid Corp. (NYSE:CTV) (the “Company”), a leading software platform for the creation, delivery, measurement, and optimization of advertising across connected TV (CTV), ...

, source: Business Insider

Innovid Inc. ( (CTV)) has released its Q3 earnings. Here is a breakdown of the information Innovid Inc. presented to its investors. Innovid Corp. is an independent software platform headquartered in ...

, source: TV Technology

NEW YORK—Innovid Corp. has announced an expanded agreement with NBCUniversal that will see Innovid supplying cross-platform, outcome-based KPIs or key performance indicators for local marketers across ...

Innovid Corp. Competitors & Peer Analysis - Technology Sector

Comparative analysis of Innovid Corp. against industry peers and competitors in the Technology sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACIW Unlock Forecast - 30 Days FREE Trial $5314M 21.2x 3.8x
ADBE Unlock Forecast - 30 Days FREE Trial $151343M 22.0x 13.2x
ADSK Unlock Forecast - 30 Days FREE Trial $63742M 61.0x 24.4x
AEYE Unlock Forecast - 30 Days FREE Trial $166M -61.5x 22.6x
AI Unlock Forecast - 30 Days FREE Trial $2224M -16.8x 2.8x
AIFF Unlock Forecast - 30 Days FREE Trial $39M -4.2x 7.5x
AILE Unlock Forecast - 30 Days FREE Trial $148M x 50.7x
AILEW Unlock Forecast - 30 Days FREE Trial $9M x 3.1x
AISP Unlock Forecast - 30 Days FREE Trial $94M x -7.3x
AISPW Unlock Forecast - 30 Days FREE Trial $17M x -1.3x
ALKT Unlock Forecast - 30 Days FREE Trial $2632M -75.9x 7.7x
ALRM Unlock Forecast - 30 Days FREE Trial $3579M 27.9x 4.5x
ALSAF Unlock Forecast - 30 Days FREE Trial $39M x x
ALSUF Unlock Forecast - 30 Days FREE Trial $6M x x
ALTR Unlock Forecast - 30 Days FREE Trial $0M 360.3x 0.0x
AMPL Unlock Forecast - 30 Days FREE Trial $0M -16.9x 0.0x
AMST Unlock Forecast - 30 Days FREE Trial $10M -2.6x 7.9x
ANSS Unlock Forecast - 30 Days FREE Trial $28149M 66.6x 5.0x
APCX Unlock Forecast - 30 Days FREE Trial $8M -0.8x 3.0x
APCXW Unlock Forecast - 30 Days FREE Trial $5M x 3.4x
API Unlock Forecast - 30 Days FREE Trial $1569M x 2.4x
APPF Unlock Forecast - 30 Days FREE Trial $0M 64.5x 0.0x
APPN Unlock Forecast - 30 Days FREE Trial $2827M -27.3x -56.8x
ASAN Unlock Forecast - 30 Days FREE Trial $3112M -12.4x 13.9x
ATHR Unlock Forecast - 30 Days FREE Trial $69M x 11.7x
AUID Unlock Forecast - 30 Days FREE Trial $54M -159.3x 7.0x
AVDX Unlock Forecast - 30 Days FREE Trial $2062M 1104.8x 3.0x
AVPT Unlock Forecast - 30 Days FREE Trial $3853M -86.5x 16.5x
AVPTW Unlock Forecast - 30 Days FREE Trial $1482M x 6.4x
AWRE Unlock Forecast - 30 Days FREE Trial $49M -8.1x 1.7x
BAND Unlock Forecast - 30 Days FREE Trial $483M -30.3x 1.3x
BASE Unlock Forecast - 30 Days FREE Trial $1348M -10.2x 10.9x
BB Unlock Forecast - 30 Days FREE Trial $2343M -11.9x 3.2x
BBAI Unlock Forecast - 30 Days FREE Trial $1868M -3.9x 7.0x
BIGC Unlock Forecast - 30 Days FREE Trial $404M -14.6x 10.6x
BILL Unlock Forecast - 30 Days FREE Trial $9589M -533.4x 2.4x
BKYI Unlock Forecast - 30 Days FREE Trial $5M -26.8x 0.6x
BL Unlock Forecast - 30 Days FREE Trial $3793M 43.1x 9.2x
BLIN Unlock Forecast - 30 Days FREE Trial $15M -2.4x 1.5x
BLKB Unlock Forecast - 30 Days FREE Trial $3396M 88.2x 38.6x
BLZE Unlock Forecast - 30 Days FREE Trial $137M -5.6x 3.2x
BMR Unlock Forecast - 30 Days FREE Trial $42M x 2.3x
BNIX Unlock Forecast - 30 Days FREE Trial $34M x -5.7x
BNIXR Unlock Forecast - 30 Days FREE Trial $1M x -0.1x
BNIXW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BNZI Unlock Forecast - 30 Days FREE Trial $6M x 1.9x
BNZIW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BOX Unlock Forecast - 30 Days FREE Trial $4696M 42.9x -16.8x
BRZE Unlock Forecast - 30 Days FREE Trial $3191M -36.2x 5.3x
BSQKZ Unlock Forecast - 30 Days FREE Trial $46199M 15.6x 2.1x
BSY Unlock Forecast - 30 Days FREE Trial $17639M 69.4x 15.2x
CANG Unlock Forecast - 30 Days FREE Trial $1067M x 0.3x
CBDW Unlock Forecast - 30 Days FREE Trial $0M x x
CCCS Unlock Forecast - 30 Days FREE Trial $6432M 396.6x 3.0x
CCLD Unlock Forecast - 30 Days FREE Trial $158M 14.0x 2.8x
CCLDO Unlock Forecast - 30 Days FREE Trial $906M 80.4x 16.2x
CCLDP Unlock Forecast - 30 Days FREE Trial $822M -14.2x 16.5x
CCRD Unlock Forecast - 30 Days FREE Trial $226M 76.0x 4.2x
CCSI Unlock Forecast - 30 Days FREE Trial $541M 6.7x -8.3x
CDNS Unlock Forecast - 30 Days FREE Trial $93861M 92.8x 18.8x
CERT Unlock Forecast - 30 Days FREE Trial $1823M 228.4x 1.7x
CFLT Unlock Forecast - 30 Days FREE Trial $6455M -15.7x 7.7x
CGNT Unlock Forecast - 30 Days FREE Trial $673M x 3.4x
CHKP Unlock Forecast - 30 Days FREE Trial $22136M x 7.9x
CLBT Unlock Forecast - 30 Days FREE Trial $4190M x 10.3x
CLPS Unlock Forecast - 30 Days FREE Trial $13M x 0.8x
COUR Unlock Forecast - 30 Days FREE Trial $1794M -14.2x 2.9x
CRM Unlock Forecast - 30 Days FREE Trial $234506M 35.2x 3.8x
CRNC Unlock Forecast - 30 Days FREE Trial $449M -0.5x 2.9x
CRWD Unlock Forecast - 30 Days FREE Trial $109768M 4606.3x 29.2x
CRWV Unlock Forecast - 30 Days FREE Trial $59331M x 22.3x
CTV Unlock Forecast - 30 Days FREE Trial $466M -21.6x 2.3x
CVLT Unlock Forecast - 30 Days FREE Trial $7968M 98.3x 21.9x
CWAN Unlock Forecast - 30 Days FREE Trial $5034M 12.4x 2.6x
CXAI Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
CXAIW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
CXM Unlock Forecast - 30 Days FREE Trial $2041M 17.0x 3.8x
CYBR Unlock Forecast - 30 Days FREE Trial $23048M x 9.7x
DAY Unlock Forecast - 30 Days FREE Trial $11163M 227.8x 4.1x
DBX Unlock Forecast - 30 Days FREE Trial $0M 17.8x 0.0x
DDD Unlock Forecast - 30 Days FREE Trial $412M -3.9x 1.7x
DDOG Unlock Forecast - 30 Days FREE Trial $49316M 395.9x 15.4x
DH Unlock Forecast - 30 Days FREE Trial $617M -1.3x 2.0x
DOCU Unlock Forecast - 30 Days FREE Trial $16991M 60.5x 8.6x
DOMO Unlock Forecast - 30 Days FREE Trial $0M -3.7x 0.0x
DRTTF Unlock Forecast - 30 Days FREE Trial $102M 26.4x 3.0x
DSGX Unlock Forecast - 30 Days FREE Trial $9135M x 6.1x
DT Unlock Forecast - 30 Days FREE Trial $14913M 30.3x 5.5x
DTSS Unlock Forecast - 30 Days FREE Trial $16M -6.8x 5.5x
DUOL Unlock Forecast - 30 Days FREE Trial $15017M 128.2x 15.4x
DUOT Unlock Forecast - 30 Days FREE Trial $91M -2.8x 17.8x
EA Unlock Forecast - 30 Days FREE Trial $43785M 42.0x 7.2x
EGAN Unlock Forecast - 30 Days FREE Trial $232M 7.2x 2.9x
ENFN Unlock Forecast - 30 Days FREE Trial $0M 277.3x 0.0x
ESTC Unlock Forecast - 30 Days FREE Trial $10000M 24.9x 12.3x
EVCM Unlock Forecast - 30 Days FREE Trial $2190M -59.0x 2.9x
EXFY Unlock Forecast - 30 Days FREE Trial $176M -12.3x 1.3x
FAAS Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
FAASW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
FALC Unlock Forecast - 30 Days FREE Trial $1M x x
FATN Unlock Forecast - 30 Days FREE Trial $89M x 4.4x
FCUL Unlock Forecast - 30 Days FREE Trial $11M x 233.2x
FNGR Unlock Forecast - 30 Days FREE Trial $96M -16.8x 5.9x
FROG Unlock Forecast - 30 Days FREE Trial $5817M -60.2x 7.0x
FRSH Unlock Forecast - 30 Days FREE Trial $3708M -49.0x 3.8x
FRSX Unlock Forecast - 30 Days FREE Trial $1614M x 272.2x
FRZT Unlock Forecast - 30 Days FREE Trial $2M x x
FSLY Unlock Forecast - 30 Days FREE Trial $1117M -8.6x 1.2x
GDYN Unlock Forecast - 30 Days FREE Trial $888M 2810.7x 1.7x
GEG Unlock Forecast - 30 Days FREE Trial $122M 9.5x 1.7x
GEGGL Unlock Forecast - 30 Days FREE Trial $1098M 85.2x 15.6x
GEN Unlock Forecast - 30 Days FREE Trial $18787M 27.7x 8.3x
GENVR Unlock Forecast - 30 Days FREE Trial $5663M x 2.5x
GHST Unlock Forecast - 30 Days FREE Trial $5M x x
GLBE Unlock Forecast - 30 Days FREE Trial $6035M x 6.8x
GMGI Unlock Forecast - 30 Days FREE Trial $146M -247.8x 1.2x
GTIC Unlock Forecast - 30 Days FREE Trial $0M 0.1x x
GTLB Unlock Forecast - 30 Days FREE Trial $8743M 654.1x 10.1x
GTM Unlock Forecast - 30 Days FREE Trial $3481M x 2.1x
GWRE Unlock Forecast - 30 Days FREE Trial $21730M 311.3x 14.9x
GXAI Unlock Forecast - 30 Days FREE Trial $11M -1.3x 0.7x
HPAI Unlock Forecast - 30 Days FREE Trial $148M x 9.1x
HUBS Unlock Forecast - 30 Days FREE Trial $25901M -5033.1x 12.5x
ICCT Unlock Forecast - 30 Days FREE Trial $34M x -11.4x
IDAI Unlock Forecast - 30 Days FREE Trial $8M -0.7x 3.2x
IDN Unlock Forecast - 30 Days FREE Trial $102M -52.1x 5.8x
INFA Unlock Forecast - 30 Days FREE Trial $7501M 3931.5x 3.2x
INLX Unlock Forecast - 30 Days FREE Trial $51M 1318.3x 4.4x
INSE Unlock Forecast - 30 Days FREE Trial $272M 4.5x -116.0x
INTA Unlock Forecast - 30 Days FREE Trial $3698M -173.7x 7.1x
INTU Unlock Forecast - 30 Days FREE Trial $182827M 47.3x 9.3x
IVDA Unlock Forecast - 30 Days FREE Trial $6M -7.5x 0.8x
IVDAW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
JAMF Unlock Forecast - 30 Days FREE Trial $1407M -22.8x 1.8x
KC Unlock Forecast - 30 Days FREE Trial $64936M x 6.9x
KLTR Unlock Forecast - 30 Days FREE Trial $264M 17.7x 15.6x
KVYO Unlock Forecast - 30 Days FREE Trial $8723M -19.1x 8.0x
LAW Unlock Forecast - 30 Days FREE Trial $357M -12.7x 2.6x
LFLY Unlock Forecast - 30 Days FREE Trial $1M -0.3x -4.0x
LFLYW Unlock Forecast - 30 Days FREE Trial $1M x -0.1x
LGTY Unlock Forecast - 30 Days FREE Trial $441M 27.8x 3.4x
LPSN Unlock Forecast - 30 Days FREE Trial $86M -0.5x -1.2x
LTESF Unlock Forecast - 30 Days FREE Trial $0M x x
LTRY Unlock Forecast - 30 Days FREE Trial $11M -0.1x 0.4x
LTRYW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
MANH Unlock Forecast - 30 Days FREE Trial $13247M 59.9x 47.5x
MAPS Unlock Forecast - 30 Days FREE Trial $174M -10.7x 5.9x
MAPSW Unlock Forecast - 30 Days FREE Trial $5M x 0.2x
MBLY Unlock Forecast - 30 Days FREE Trial $11051M -9.4x 0.9x
MDB Unlock Forecast - 30 Days FREE Trial $18161M -85.8x 6.0x
MGIC Unlock Forecast - 30 Days FREE Trial $1040M x 5.0x
MKTW Unlock Forecast - 30 Days FREE Trial $0M 6.0x 0.0x
MLNK Unlock Forecast - 30 Days FREE Trial $1523M -46.1x 3.9x
MNDY Unlock Forecast - 30 Days FREE Trial $10202M x 8.6x
MQ Unlock Forecast - 30 Days FREE Trial $2806M 51.0x 3.3x
MSFT Unlock Forecast - 30 Days FREE Trial $3806403M 37.4x 11.1x
MSGM Unlock Forecast - 30 Days FREE Trial $0M -0.7x 0.0x
MTBLY Unlock Forecast - 30 Days FREE Trial $1614M x 33.4x
MTTR Unlock Forecast - 30 Days FREE Trial $1763M -5.6x 4.4x
MYPS Unlock Forecast - 30 Days FREE Trial $121M -24.1x 0.5x
MYPSW Unlock Forecast - 30 Days FREE Trial $2M -0.4x 0.0x
MYSZ Unlock Forecast - 30 Days FREE Trial $4M -0.3x 0.5x
NABL Unlock Forecast - 30 Days FREE Trial $1552M 541.9x 1.9x
NCNO Unlock Forecast - 30 Days FREE Trial $3508M -119.0x 3.3x
NCSYF Unlock Forecast - 30 Days FREE Trial $9446M x 2.6x
NET Unlock Forecast - 30 Days FREE Trial $0M -419.2x 0.0x
NICE Unlock Forecast - 30 Days FREE Trial $9390M x 2.6x
NOW Unlock Forecast - 30 Days FREE Trial $194471M 117.1x 17.8x
NTNX Unlock Forecast - 30 Days FREE Trial $14701M -280.8x -21.5x
NTWK Unlock Forecast - 30 Days FREE Trial $45M 32.6x 1.3x
OKTA Unlock Forecast - 30 Days FREE Trial $0M -430.9x 0.0x
ONTF Unlock Forecast - 30 Days FREE Trial $234M -6.7x 1.6x
ORCL Unlock Forecast - 30 Days FREE Trial $684063M 36.4x 33.5x
OS Unlock Forecast - 30 Days FREE Trial $5644M x 14.6x
PATH Unlock Forecast - 30 Days FREE Trial $6181M 306.5x 3.7x
PAYC Unlock Forecast - 30 Days FREE Trial $12539M 30.2x 7.0x
PCOR Unlock Forecast - 30 Days FREE Trial $10453M -134.0x 8.6x
PCTY Unlock Forecast - 30 Days FREE Trial $9595M 42.3x 7.8x
PD Unlock Forecast - 30 Days FREE Trial $1689M -23.5x 9.3x
PDFS Unlock Forecast - 30 Days FREE Trial $923M -1123.7x 3.7x
PDYN Unlock Forecast - 30 Days FREE Trial $453M -3.0x 16.0x
PDYNW Unlock Forecast - 30 Days FREE Trial $4M 0.0x 0.1x
PLTR Unlock Forecast - 30 Days FREE Trial $445652M 583.9x 75.2x
PRCH Unlock Forecast - 30 Days FREE Trial $149M 2.7x -22.8x
PRGS Unlock Forecast - 30 Days FREE Trial $1867M 32.4x 4.1x
PTC Unlock Forecast - 30 Days FREE Trial $24780M 48.3x 7.1x
PYCR Unlock Forecast - 30 Days FREE Trial $4088M -69.4x 3.1x
QLYS Unlock Forecast - 30 Days FREE Trial $4891M 26.4x 9.6x
QTWO Unlock Forecast - 30 Days FREE Trial $5339M 1093.1x 9.1x
QUBT Unlock Forecast - 30 Days FREE Trial $2593M -23.3x 11.7x
RBLX Unlock Forecast - 30 Days FREE Trial $88333M -35.7x 250.1x
RBRK Unlock Forecast - 30 Days FREE Trial $14400M x 0.0x
RCAT Unlock Forecast - 30 Days FREE Trial $1025M -91.1x 35.4x
RDVT Unlock Forecast - 30 Days FREE Trial $706M 81.1x 7.3x
RPD Unlock Forecast - 30 Days FREE Trial $1266M 49.6x 14.0x
RTCJF Unlock Forecast - 30 Days FREE Trial $35M x 1.3x
S Unlock Forecast - 30 Days FREE Trial $6026M -25.6x 4.0x
SAIL Unlock Forecast - 30 Days FREE Trial $12028M -73.2x 1.8x
SBET Unlock Forecast - 30 Days FREE Trial $1171M x 2.6x
SCWX Unlock Forecast - 30 Days FREE Trial $0M -9.8x 0.0x
SEMR Unlock Forecast - 30 Days FREE Trial $1131M 169.4x 4.1x
SHOP Unlock Forecast - 30 Days FREE Trial $187608M x 15.5x
SKIL Unlock Forecast - 30 Days FREE Trial $136M -1.4x 2.2x
SMAR Unlock Forecast - 30 Days FREE Trial $4014M -19.6x 8.5x
SMSI Unlock Forecast - 30 Days FREE Trial $14M -0.2x 0.6x
SNAL Unlock Forecast - 30 Days FREE Trial $0M -7.0x 0.0x
SNOW Unlock Forecast - 30 Days FREE Trial $0M -54.7x 0.0x
SNPS Unlock Forecast - 30 Days FREE Trial $78903M 39.5x 2.9x
SOUN Unlock Forecast - 30 Days FREE Trial $15M -10.2x -27.1x
SOUNW Unlock Forecast - 30 Days FREE Trial $M x x
SPNS Unlock Forecast - 30 Days FREE Trial $2415M x 5.0x
SPSC Unlock Forecast - 30 Days FREE Trial $4024M 48.5x 4.2x
SPT Unlock Forecast - 30 Days FREE Trial $0M -27.5x 0.0x
SQ Unlock Forecast - 30 Days FREE Trial $0M 68.5x 0.0x
SSNC Unlock Forecast - 30 Days FREE Trial $22858M 28.4x 3.3x
SSTI Unlock Forecast - 30 Days FREE Trial $159M -38.0x 2.1x
SVCO Unlock Forecast - 30 Days FREE Trial $150M x 1.9x
SWI Unlock Forecast - 30 Days FREE Trial $3173M 86.3x 2.3x
TAOP Unlock Forecast - 30 Days FREE Trial $20M x 1.3x
TDC Unlock Forecast - 30 Days FREE Trial $2052M 18.7x 11.7x
TEAM Unlock Forecast - 30 Days FREE Trial $45779M -233.9x 34.0x
TENB Unlock Forecast - 30 Days FREE Trial $3604M -81.5x 10.3x
TFLM Unlock Forecast - 30 Days FREE Trial $1M x x
TTAN Unlock Forecast - 30 Days FREE Trial $10321M x 6.9x
TTWO Unlock Forecast - 30 Days FREE Trial $45410M -9.7x 13.1x
TWLO Unlock Forecast - 30 Days FREE Trial $16447M 812.5x 2.0x
TYL Unlock Forecast - 30 Days FREE Trial $26240M 85.5x 7.2x
U Unlock Forecast - 30 Days FREE Trial $19727M -13.5x 6.2x
UPLD Unlock Forecast - 30 Days FREE Trial $55M -1.2x -1.5x
VBIX Unlock Forecast - 30 Days FREE Trial $32M x 7.1x
VEEV Unlock Forecast - 30 Days FREE Trial $46239M 57.1x 7.0x
VERX Unlock Forecast - 30 Days FREE Trial $0M -368.3x 0.0x
VPRB Unlock Forecast - 30 Days FREE Trial $M x x
VRNS Unlock Forecast - 30 Days FREE Trial $6314M -27.4x 18.5x
VWAV Unlock Forecast - 30 Days FREE Trial $25M x x
WBSR Unlock Forecast - 30 Days FREE Trial $M x x
WEAV Unlock Forecast - 30 Days FREE Trial $590M -36.7x 7.5x
WFCF Unlock Forecast - 30 Days FREE Trial $64M 31.4x 6.5x
WHEN Unlock Forecast - 30 Days FREE Trial $411M x 303.5x
WIMI Unlock Forecast - 30 Days FREE Trial $707M x 0.6x
WK Unlock Forecast - 30 Days FREE Trial $0M -70.2x 0.0x
XPER Unlock Forecast - 30 Days FREE Trial $350M -4.3x 0.8x
XYZ Unlock Forecast - 30 Days FREE Trial $45626M 15.4x 2.1x
YOU Unlock Forecast - 30 Days FREE Trial $2403M -51.2x 18.6x
ZDGE Unlock Forecast - 30 Days FREE Trial $42M -4.8x 1.5x
ZETA Unlock Forecast - 30 Days FREE Trial $4374M -26.5x 6.5x
ZI Unlock Forecast - 30 Days FREE Trial $3183M 346.5x 1.9x
ZSPC Unlock Forecast - 30 Days FREE Trial $37M x -3.2x
ZUO Unlock Forecast - 30 Days FREE Trial $0M -32.2x 0.0x

Frequently Asked Questions - Innovid Corp. Stock Forecast

How accurate are Innovid Corp. stock predictions?

Our AI model demonstrates 59% historical accuracy for CTV predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Innovid Corp. stock price forecasts?

Our analysis considers Innovid Corp.'s financial metrics, Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Innovid Corp. a good investment in 2025?

Based on our AI analysis, Innovid Corp. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Innovid Corp. forecasts updated?

Innovid Corp. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Innovid Corp. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Innovid Corp. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...